Submit the final report for the HEPLISAV-B post-marketing study
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- by 28 Feb 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Final report for HEPLISAV-B post-marketing study expected in the second quarter”
What we found
Evidence strength A What the grades mean
Filings from August and November 2021 say the final study report was still being prepared for FDA submission. The 10-K filed 2022-02-28 reports it had been submitted, after the June 2021 deadline.
-
A Dynavax Technologies Corp. 10-Q filed 2021-11-04
“with the study report being prepared for submission to the FDA” ✓ confirmed on the page
-
A Dynavax Technologies Corp. 10-K filed 2022-02-28
“the final study report has been submitted to the FDA” ✓ confirmed on the page
-
A Dynavax Technologies Corp. 10-Q filed 2021-08-04
“final results were presented in April 2021, with the study report being prepared for submission to the FDA” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Other
- Indicative materiality
- Low rules
- Action
- Submit
- Deliverable
- Final report for HEPLISAV-B post-marketing study
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Dynavax Technologies Corp.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C029142-024635 · Corrections policy